Literature DB >> 19302036

Microglial physiology: unique stimuli, specialized responses.

Richard M Ransohoff1, V Hugh Perry.   

Abstract

Microglia, the macrophages of the central nervous system parenchyma, have in the normal healthy brain a distinct phenotype induced by molecules expressed on or secreted by adjacent neurons and astrocytes, and this phenotype is maintained in part by virtue of the blood-brain barrier's exclusion of serum components. Microglia are continually active, their processes palpating and surveying their local microenvironment. The microglia rapidly change their phenotype in response to any disturbance of nervous system homeostasis and are commonly referred to as activated on the basis of the changes in their morphology or expression of cell surface antigens. A wealth of data now demonstrate that the microglia have very diverse effector functions, in line with macrophage populations in other organs. The term activated microglia needs to be qualified to reflect the distinct and very different states of activation-associated effector functions in different disease states. Manipulating the effector functions of microglia has the potential to modify the outcome of diverse neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302036     DOI: 10.1146/annurev.immunol.021908.132528

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  704 in total

1.  Mechanisms Involved in the Remyelinating Effect of Sildenafil.

Authors:  Daniela Díaz-Lucena; María Gutierrez-Mecinas; Beatriz Moreno; José Lupicinio Martínez-Sánchez; Paula Pifarré; Agustina García
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-03       Impact factor: 4.147

2.  Primary murine microglia are resistant to nitric oxide inhibition of indoleamine 2,3-dioxygenase.

Authors:  Yunxia Wang; Marcus A Lawson; Keith W Kelley; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2010-05-06       Impact factor: 7.217

Review 3.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

4.  The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood.

Authors:  Makiko Mizutani; Paula A Pino; Noah Saederup; Israel F Charo; Richard M Ransohoff; Astrid E Cardona
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

Review 5.  Cognitive and behavioral consequences of impaired immunoregulation in aging.

Authors:  Angela W Corona; Ashley M Fenn; Jonathan P Godbout
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-20       Impact factor: 4.147

Review 6.  Microglial voltage-gated proton channel Hv1 in ischemic stroke.

Authors:  Long-Jun Wu
Journal:  Transl Stroke Res       Date:  2013-10-03       Impact factor: 6.829

Review 7.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

8.  Neuroprotective effect of diclofenac on chlorpromazine induced catalepsy in rats.

Authors:  Sadaf Naeem; Rahila Najam; Saira Saeed Khan; Talat Mirza; Bushra Sikandar
Journal:  Metab Brain Dis       Date:  2019-05-04       Impact factor: 3.584

9.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

10.  Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.

Authors:  Erik C B Johnson; Eric B Dammer; Duc M Duong; Lingyan Ping; Maotian Zhou; Luming Yin; Lenora A Higginbotham; Andrew Guajardo; Bartholomew White; Juan C Troncoso; Madhav Thambisetty; Thomas J Montine; Edward B Lee; John Q Trojanowski; Thomas G Beach; Eric M Reiman; Vahram Haroutunian; Minghui Wang; Eric Schadt; Bin Zhang; Dennis W Dickson; Nilüfer Ertekin-Taner; Todd E Golde; Vladislav A Petyuk; Philip L De Jager; David A Bennett; Thomas S Wingo; Srikant Rangaraju; Ihab Hajjar; Joshua M Shulman; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Nat Med       Date:  2020-04-13       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.